Cough and cold medicine sales revenue in the CIS 2020, by country

Published by Statista Research Department, Oct 24, 2022
In 2020, Russia's cough and cold medicine sales revenue was highest than the rest of the CIS countries' combined and amounted to over 2.1 billion U.S. dollars. Uzbekistan ranked second, with 190 million U.S. dollars in revenue.

Sales revenue of cough and cold medicine in the Commonwealth of Independent States (CIS) in 2020, by country (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2021

Region

Asia, Europe

Survey time period

2020

Supplementary notes

Cough and Cold Market: EphMRA3: J05B, L03A, L03B, R01A, R02A, R05A, R05C, R05D.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

2

Other regions

10

Related statistics

2

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RussiaGlobal pharmaceutical industryTop pharmaceutical drugsHealthcare in RussiaCoronavirus (COVID-19) in Russia
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu